Table (2).
# | Mutation Name |
Ref/Patent | Phenotype | Mechanism |
---|---|---|---|---|
1 |
svir017 (cop1 in CloDF13) |
[41, 42] | Increased PCN | Increased P2 expression (stabilizes secondary structure in promoter) |
2 | [83] | Increased PCN | Increased P2 expression | |
3 | pOPIΔ6 (same in pBR322) |
[54, 55] | Increased PCN (200–300 copies) |
Read-through transcription of RNA I, altering its secondary structure |
4 | inc4 | [45] | Increased PCN(3×) | |
5 | inc1 | [45] | Increased PCN (2×) | |
6 | inc9 | [45] | Increased PCN (1.5×) | SL3 disruption |
7 | Patent | [48] | Increased PCN | |
8 | svir 3,115 | [44] | Runaway plasmid replication |
|
9 |
svir 2,7; inc1 inc2 pWT11cop |
[44, 45] | Increased Increased (7×) New compatibility group |
|
10 | svir12 | [44] | Increased | |
11 | svir102 | [44] | ||
12 | svir19 | |||
13 | inc3 | [45] | Increased (1.5×) Altered compatibility |
Decreased inhibition by RNAI due to weaker interaction to homologous residues in unpaired loop |
14 |
svir002 (C to A in pUC) |
[41, 51, 65] | Increased (Temperature-dependent) |
Stabilizes α, β; conformation less sensitive to inhibition |
15 | pEW2705 | [64, 52] | Te- dependent PCN 30 °C normal 42 °C runaway (host affected) Growth phase-dependent @ 37 °C Exp: 2–4× Sat: 20× |
Stabilizes α, β; conformation less sensitive to inhibition because antitail is hidden in a stem |
16 | pMM7 | [64, 52, 53] | ~ pEW2705 (less Ts?) |
|
17 | pMM4 | [64, 52, 53] | ~ pEW2705 (less Ts?) |
|
18 | pMM1 | [64, 52] | ~ pEW2705 |
Mutations increasing plasmid copy number, their names, phenotype and probable mechanism of action are listed. The number in column 1 identifies the mutation presented in Fig. (5). inc=incompatibility mutants, allow plasmids pNT7 and pMB9 to be stably inherited in the same cell. svir= suppressors of virulence. cop=copy number. PCN=plasmid copy number